Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer. Tan R, Yun C, Seetasith A, Sheinson D, et al. Oncologist 2022;27:236-243.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tan R, Yun C, Seetasith A, Sheinson D, et al. Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer. Oncologist 2022;27:236-243.
PMID: 35274714